Hyperuricemia or Gout

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Hyperuricemia or Gout trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 5 trials

RecruitingNot Applicable

NCT07141888

The Effects of a Probiotic Food Supplement in Hyperuricaemia

The overall aim of the project is to determine whether a daily intake of health-promoting bacteria, known as probiotics, with or without a dietary fiber, affect…

Sweden99 participantsStarted 2025-12-16

Treatment: Placebo (no active ingredient), Probiotics

RecruitingPhase 4

NCT06834230

Effect of Dotinurad in Hyperuricemia With Hypertension

The effect of dotinurad on CAVI (cardio-ankle vascular index) will be compared with that of febuxostat in patients with hyperuricemia complicated by hypertensio…

Japan360 participantsStarted 2025-03-28

Treatment: Dotinurad, Febuxostat

RecruitingNot Applicable

NCT07002762

Clinical Efficacy Trial of Burdock Root Extract in Patients With Asymptomatic Hyperuricaemia

Multicentre, double-blind, randomized, placebo-controlled trial of the clinical efficacy of burdock root extract in patients with asymptomatic hyperuricemia, wi…

Ukraine100 participantsStarted 2025-03-12

Treatment: Burdock ( Arctium lappa L.) root extract in a form of a nutritional additive, Placebo

RecruitingPhase 4

NCT06966635

Exploratory Study on the Treatment of Gout With Potassium Citrate Sustained-release Tablets

To evaluate whether alkalization has the effect of lowering uric acid and reducing gout flare and determine whether alkalization has a role in the prevention an…

China312 participantsStarted 2024-04-10

Treatment: Sodium Bicarbonate Oral Capsule, Potassium Citrate Tablets

RecruitingNot Applicable

NCT06694012

Osaka Cardiometabolic Epidemiological Study: Ohtori Study Part 2

The aim of this study is to investigate the relationship between body fat distribution measured by CT scan and related risk factors with the risk of incident me…

Japan2,000 participantsStarted 2024-11-01

All recent trials (30 shown)

CompletedPhase 1

NCT05127772

A Clinical Trial of HEC93077 in Chinese Healthy Subjects and HUA Patients With Single or Multiple Dosing

A phase 1 clinical trial of HEC93077,to evaluate the safety ,PK,PD and food effect in Chinese healthy subjects and HUA patients after single or multiple dosing.

China126 participantsStarted 2021-11-22

Treatment: HEC93077, Placebo

Not Yet RecruitingPhase 1

NCT07346027

Safety and Food Effect on Single-Dose Bioavailability of F-02-2-Na in Healthy Adult Subjects

The study is to evaluate the impact of food on the pharmacokinetics of F-02-2-Na in healthy adult subjects by observing the changes in the drug's pharmacokineti…

China12 participantsStarted 2026-02-01

Treatment: Fasting administration of F-02-2-Na (50mg) - Fed administration of F-02-2-Na (50mg), Fed administration of F-02-2-Na (50mg) - Fasting administration of F-02-2-Na (50mg)

Hyperuricemia or Gout

Trial phase breakdown

Trial status

Actively recruiting — 5 trials

The Effects of a Probiotic Food Supplement in Hyperuricaemia

Effect of Dotinurad in Hyperuricemia With Hypertension

Clinical Efficacy Trial of Burdock Root Extract in Patients With Asymptomatic Hyperuricaemia

Exploratory Study on the Treatment of Gout With Potassium Citrate Sustained-release Tablets

Osaka Cardiometabolic Epidemiological Study: Ohtori Study Part 2

All recent trials (30 shown)

A Clinical Trial of HEC93077 in Chinese Healthy Subjects and HUA Patients With Single or Multiple Dosing

Safety and Food Effect on Single-Dose Bioavailability of F-02-2-Na in Healthy Adult Subjects

Trial phase breakdown

Trial status

Actively recruiting — 5 trials

The Effects of a Probiotic Food Supplement in Hyperuricaemia

Effect of Dotinurad in Hyperuricemia With Hypertension

Clinical Efficacy Trial of Burdock Root Extract in Patients With Asymptomatic Hyperuricaemia

Exploratory Study on the Treatment of Gout With Potassium Citrate Sustained-release Tablets

Osaka Cardiometabolic Epidemiological Study: Ohtori Study Part 2

All recent trials (30 shown)

A Clinical Trial of HEC93077 in Chinese Healthy Subjects and HUA Patients With Single or Multiple Dosing

Safety and Food Effect on Single-Dose Bioavailability of F-02-2-Na in Healthy Adult Subjects

A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Oral F-02-2-Na Tablets in Adult Subjects

Phase 2 to Assess Efficacy and Safety in AR882 Alone or in Combination With Allopurinol in Patients With Tophaceous Gout

SAD,MAD and Food Effect Study of SAP-001 Tablets in Chinese Subjects

Low-dose Colchicine With or Without Stepwise Dose Titration of Febuxostat for Flare Prophylaxis in Gout

A Study to Assess the Efficacy, Safety, and Pharmacokinetics of ABP-671 in Patients With Gout or Hyperuricemia

D-0120 Safety and PK/PD Study in China

Phase 2a Study of AR882 Alone and in Combination With Febuxostat or Allopurinol in Gout Patients

Phase II Dose Finding Study of RDEA3170 Versus Placebo in Japanese Patients With Gout or Asymptomatic Hyperuricemia

Zurig (Febuxostat) 40mg Efficacy and Safety Trial

Genetics of Hyperuricemia Therapy in Hmong

Study of FYU-981 in Hyperuricemia With or Without Gout

Benzbromarone-Controlled, Double-Blind, Comparative Study of FYU-981 in Hyperuricemia With or Without Gout

Study of FYU-981 in Hyperuricemic Outpatients With or Without Gout (Effect on Two Hyperuricemic Types)

Febuxostat-Controlled, Double-Blind, Comparative Study of FYU-981 in Hyperuricemia With or Without Gout

The Efficiency and Safety of Sodium Bicarbonate on Uric Acid in Patients With Asymptomatic Hyperuricemia or Gout

Effect of Topiroxostat on Urinary Albumin Excretion Early Stage Diabetic Nephropathy and Hyperuricemia With or Without G…

Study of FYU-981 in Hyperuricemia With or Without Gout

A PD/Safety Study of RDEA3170 in Combination With Febuxostat for Treating Gout or Asymptomatic Hyperuricemia Patients